NIDA plans to fund a hybrid course teaching life science researchers how to turn substance use disorder research into marketable products through entrepreneurship and product development training.
Funder: National Institutes of Health (NIH)
Due Dates: October 1, 2026 (forecasted)
Funding Amounts: Award ceiling and total funding not specified; cooperative agreement mechanism; details to be announced in full solicitation.
Summary: Supports the development and delivery of a hybrid entrepreneurship education program focused on product development for life science researchers working in substance use disorder (SUD) research.
Key Information: This is a forecasted opportunity; applications are not being accepted yet.
The National Institute on Drug Abuse (NIDA), part of the NIH, is forecasting a funding opportunity to establish a high-impact entrepreneurship education program tailored for life science researchers in the field of substance use disorder (SUD). The goal is to provide a hybrid-format course—requiring both in-person and virtual components—that equips academic and other domestic SUD researchers with the skills needed to translate scientific discoveries into viable biomedical products.
The envisioned curriculum will cover early-stage innovation, market evaluation, commercialization pathways, customer discovery, intellectual property, regulatory strategy, reimbursement, and funding sources such as SBIR/STTR. The program aims to bridge the gap between academic research and product development, ultimately accelerating solutions for SUD to reach those in need.